Name: Adiponectin: Implications in Health and Diseases (en Inglés)
Price: 58.76 USD
Availability: InStock
Author: Gupta, Seema ; Satyawali, V. N. ; Shukla, Sanjeev Kumar
ISBN: 9786138920915

portada Adiponectin: Implications in Health and Diseases (en Inglés)

Adiponectin: Implications in Health and Diseases (en Inglés)

Formato

Libro Físico

Autor

Editorial

Idioma

Inglés

N° páginas

Encuadernación

Tapa Blanda

Dimensiones

22.9 x 15.2 x 0.4 cm

Peso

0.11 kg.

ISBN13

9786138920915

Categorías

Empresa y gestión

Adiponectin: Implications in Health and Diseases (en Inglés)

Seema Gupta (Autor) · V. N. Satyawali (Autor) · Sanjeev Kumar Shukla (Autor) · Scholars' Press · Tapa Blanda

Libro Nuevo Importado

Envío: 24 a 31 días háb.

$ 117.52$ 58.76

-50%

Costos de importación incluídos en el precio ✅

Libro Nuevo

Quedan 10 unidades

$ 58.76

Llega entre el 24 Jul y el 06 Ago a Quito, Pichincha. Seleccionar ubicación

Agregar a lista de deseos

Reseña del libro "Adiponectin: Implications in Health and Diseases (en Inglés)"

Adiponectin is the name originated from its distinctive molecular characteristics ("adipo" ] "nectin" = "adiponectin") as it is a product of novel gene apM1 which is specific to adipocytes and uniquely possess a collagen-like domain with a nectin-like adherent property. Adiponectin is the most abundant peptide secreted by adipocytes, whose altered levels play a central role in obesity-related diseases, including insulin resistance/type 2 diabetes and cardiovascular disease. It is known to exert anti-diabetic and anti-atherosclerotic effects via adiponectin receptors (Adipors); AdipoR1 and AdipoR2. Adiponectin has direct actions in liver, skeletal muscle and the vasculature. Adiponectin administration in humans and rodents has insulin-sensitizing, anti-atherogenic, and anti-inﬂammatory effects and in certain settings, also decreases body weight. Therefore, adiponectin replacement therapy in humans may suggest potential versatile therapeutic targets in the treatment of obesity, insulin resistance/type 2 diabetes, cardiovascular disease and atherosclerosis.